Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,616 | -10,884 | -9,450 | -3,470 | -1,965 |
| Depreciation Amortization | 36 | 17 | 210 | 63 | 4 |
| Accounts payable and accrued liabilities | 728 | -60 | 132 | 378 | 294 |
| Other Working Capital | 1,044 | 582 | 268 | 334 | 292 |
| Other Operating Activity | 2,968 | 1,828 | 3,127 | 58 | 141 |
| Operating Cash Flow | $-22,840 | $-8,517 | $-5,713 | $-2,638 | $-1,233 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 3 | N/A |
| PPE Investments | -319 | -15 | -36 | -3 | -34 |
| Other Investing Activity | -73 | 0 | 0 | 0 | -60 |
| Investing Cash Flow | $-392 | $-15 | $-36 | $0 | $-94 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 280 | 320 | 500 | 50 |
| Debt Issued | N/A | N/A | 390 | 1,501 | N/A |
| Debt Repayment | N/A | N/A | -150 | N/A | N/A |
| Common Stock Issued | 53,497 | 14,670 | 6,933 | 612 | 1,342 |
| Other Financing Activity | -280 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $53,217 | $14,950 | $7,493 | $2,613 | $1,392 |
| Exchange Rate Effect | -3 | -1 | N/A | N/A | N/A |
| Beginning Cash Position | 8,202 | 1,785 | 41 | 65 | 1 |
| End Cash Position | 38,184 | 8,202 | 1,785 | 41 | 65 |
| Net Cash Flow | $29,982 | $6,417 | $1,744 | $-24 | $64 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,840 | -8,517 | -5,713 | -2,638 | -1,233 |
| Capital Expenditure | -319 | -15 | -36 | -3 | -34 |
| Free Cash Flow | -23,159 | -8,532 | -5,749 | -2,640 | -1,268 |